Status:
COMPLETED
Hypertension and Retinal Microvascular Dysfunction
Lead Sponsor:
University of Basel
Conditions:
Hypertension
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
Hypertension is a worldwide health care burden that affects the structure and function of the macro- and microcirculation. Non-invasive vascular biomarkers are essential to timely diagnose end organ d...
Eligibility Criteria
Inclusion
- Men and Women between 40 and 70 years of age
- hypertension (≥90 mmHg diastolic or ≥140 mmHg systolic BP during 24h monitoring or hypertensive medication) or normal blood pressure (≤85 mmHg diastolic and ≤130 mmHg systolic BP during 24h monitoring and no hypertensive medication).
Exclusion
- Any cardiovascular (CV) medication (accept for hypertensive medication in the hypertensive group)
- history of CV, pulmonary, or chronic inflammatory disease
- active smoking status
- any chronic eye disease.
Key Trial Info
Start Date :
February 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2022
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04763005
Start Date
February 12 2021
End Date
May 20 2022
Last Update
June 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Sports, Exercise and Health
Basel, Switzerland, 4052